miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. (Q36544974)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 September 2015
edit
Language Label Description Also known as
English
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.
scientific article published on 24 September 2015

    Statements

    miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit